risks of glp-1 drugs Exploring the Side Effects Receptor Agonist: To Ensure Its Optimal Positioning The GLP-1 Agonists and Obesity:
Description
10.1016/j.cmet.2022.08.003 84 WongC
Some people may also receive GLP-1 medications to manage health conditions like type 2 diabetes
37 Empagliflozin EMA product information (2023)
10.1186/s12885-023-11077-w 62 MadsenM
